Trial Profile
Study of dual therapy with rilpivirine and boosted darunavir in treatment-experienced HIV patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2017
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 24 Jan 2017 New trial record